SCHEMBL30015331

SCHEMBL30015331

O=C(Nc1ccc(C(=O)O)c(F)c1)c1ccc2c(c1)N(S(=O)(=O)c1cc(Cl)cc(Cl)c1)CCC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CPT1A P50416 14/20 1.00
CPT1B Q92523 14/20 1.00
CPT2 P23786 12/20 0.75
RORC P51449 5/20 0.61
MAPT P10636 1/20 0.55
NR1I2 O75469 1/20 0.55
RORA P35398 1/20 0.55
NR1H2 P55055 1/20 0.55
NR1H3 Q13133 1/20 0.55
RORB Q92753 1/20 0.55
NR1H4 Q96RI1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3572266 1.00 CPT1A (1.00) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL30015405 0.92 CPT1A (0.86) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL3575424 0.92 CPT1A (0.86) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL3582331 0.91 CPT1A (0.90) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL30015360 0.91 CPT1A (0.90) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL30015584 0.90 CPT1A (0.90) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL3575974 0.90 CPT1A (0.90) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL3582869 0.88 CPT1A (0.78) CPT1ACPT1BCPT2RORCMAPT
SCHEMBL3575214 0.87 CPT1A (0.82) CPT1ACPT1BCPT2RORCNR1I2
SCHEMBL3569896 0.87 CPT1A (0.80) CPT1ACPT1BCPT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022212568-A9 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2023-11-16 WO disclosed
WO-2022212568-A1 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2022-10-06 WO disclosed